Destination Wealth Management Reduces Holdings in Danaher Corporation $DHR

Posted by Brian Himes on Jun 14th, 2026

Destination Wealth Management decreased its holdings in shares of Danaher Corporation (NYSE:DHR – Free Report) by 88.8% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 21,281 shares of the conglomerate’s stock after selling 169,136 shares during the period. Destination Wealth Management’s holdings in Danaher were worth $4,872,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of DHR. Norges Bank purchased a new stake in shares of Danaher during the fourth quarter worth about $2,177,106,000. Viking Global Investors LP grew its stake in shares of Danaher by 543.9% during the second quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock worth $574,351,000 after acquiring an additional 2,455,994 shares during the last quarter. Massachusetts Financial Services Co. MA grew its stake in shares of Danaher by 104.7% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock worth $991,923,000 after acquiring an additional 2,216,789 shares during the last quarter. Generation Investment Management LLP grew its stake in shares of Danaher by 34.0% during the third quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock worth $1,319,354,000 after acquiring an additional 1,689,020 shares during the last quarter. Finally, Capital International Investors grew its stake in shares of Danaher by 8.9% during the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after acquiring an additional 1,487,768 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher News Summary

Here are the key news stories impacting Danaher this week:

Positive Sentiment: Danaher closed its $9.9 billion acquisition of Masimo, expanding its diagnostics and patient-monitoring portfolio with AI-enabled sensor technologies that could support longer-term growth. Danaher Boosts Product Portfolio With the Acquisition of Masimo
Positive Sentiment: Cepheid, a Danaher company, donated Xpert Hemorrhagic Fever panel tests to support Ebola outbreak response in Africa, highlighting the company’s diagnostic relevance and public-health role. Cepheid Delivers Xpert Hemorrhagic Fever Panel Tests to Africa
Positive Sentiment: Analysts noted strong performance in Danaher’s biotechnology unit, with bioprocessing demand and equipment orders rising, which supports the company’s 2026 growth outlook. Strong Performance Continues at DHR’s Biotechnology Unit: What’s Next?

Danaher Stock Down 0.5%

Danaher stock opened at $179.95 on Friday. The stock has a market capitalization of $127.37 billion, a PE ratio of 34.81, a price-to-earnings-growth ratio of 2.40 and a beta of 0.81. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The business has a 50 day simple moving average of $180.93 and a 200-day simple moving average of $204.78. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52.

Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same period in the previous year, the business earned $1.88 earnings per share. The business’s revenue was up 3.7% compared to the same quarter last year. On average, analysts anticipate that Danaher Corporation will post 8.45 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is currently 30.95%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on DHR shares. Rothschild & Co Redburn set a $205.00 price target on Danaher in a research note on Friday, April 17th. Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. UBS Group decreased their target price on Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Jefferies Financial Group reaffirmed a “buy” rating and set a $245.00 target price on shares of Danaher in a report on Tuesday, April 21st. Finally, Citigroup began coverage on Danaher in a report on Tuesday, May 26th. They set a “buy” rating and a $230.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $233.61.

Read Our Latest Report on DHR

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.